Potential Protection of Pre-Existent Antibodies to Human Coronavirus 229E on COVID-19 Severity

The causes of the broad spectrum of severity in COVID-19 are unknown. A protecting impact by humoral immunity from earlier infections by viruses of the SARS-CoV-2 household may clarify a light type of this illness. This examine aimed to deal with whether or not the presence of antibodies in opposition to human seasonal coronaviruses (HCoVs) may forestall extreme manifestations of COVID-19.
A cross-sectional examine was carried out in 165 members. The presence of pre-existent antibodies in opposition to the seasonal HCoV-OC43, HCoV-HKU1, HCoV-229E, and HCoV-NL63 have been detected. From all the seasonal HCoVs studied, it was solely discovered that being seropositive to HCoV-229E introduced an affiliation (p = 0.012) with creating delicate medical signs of COVID-19 or being asymptomatic.
Multinomial regression evaluation confirmed that being seropositive to HCoV-229E is related to delicate or reasonable medical signs for COVID-19. Statistical evaluation additionally confirmed that being feminine is related to being asymptomatic for SARS-CoV-2 an infection or creating delicate COVID-19.
A subgroup evaluation taking solely seropositive to HCoV-229E revealed that females usually tend to develop asymptomatic SARS-CoV-2 an infection (OR = 27.242, 95% CI 2.092-354.706, p = 0.012). Our outcomes recommend that earlier infections by HCoV-229E may forestall extra critical medical manifestations of COVID-19, however these should not the one variables that affect this occasion.

The comparative efficacy and security of anti-CD20 monoclonal antibodies for relapsing-remitting a number of sclerosis: A community meta-analysis

With the latest profitable concentrating on of B lymphocytes in sufferers with a number of sclerosis (MS), therapy with anti-CD20 monoclonal antibodies (mAbs) might characterize a promising managemental strategy, significantly for these with relapsing/remitting MS (RRMS).
A community meta-analysis was carried out based mostly on a complete search in Embase, PubMed, and the Cochrane Library to evaluate the comparative efficacy and security of at present obtainable anti-CD20 monoclonal antibodies (mAbs), together with rituximab, ocrelizumab, and ofatumumab, versus a standard comparator (interferon beta-1a [INFβ-1a]) in RRMS sufferers recruited in randomized medical trials (RCTs).
In a frequentist community meta-analytical mannequin, annualized relapse charges (ARRs) and security outcomes have been expressed as threat ratios (RRs), whereas relapse-free occasions have been expressed as odds ratios (ORs). Remedy rating was carried out utilizing P-scores. The knowledge of proof was appraised utilizing the GRADE strategy.
5 publications reported the outcomes of seven RCTs (3938 sufferers, 67.09% females). In comparison with INFβ-1a, ocrelizumab lowered the chance of ARR (RR = 0.56, 95% CI, 0.50-0.64), critical adversarial occasions (RR = 0.17, 95% CI, 0.09-0.30), and therapy discontinuation as a consequence of adversarial occasions (SAEs, RR = 0.60, 95% CI, 0.39-0.93), and it was related to larger odds of no relapses (OR = 2.47, 95% CI, 2.00-3.05).
Ocrelizumab ranked finest amongst all different remedies by way of lowering ARR and SAEs. The standard of proof was low for ocrelizumab, low to reasonable for rituximab, and excessive for ofatumumab. Additional large-sized, well-designed RCTs are wanted to corroborate the efficacy and security of ocrelizumab and different anti-CD20 mAbs in RRMS.

Fc Receptor Variants and Illness: A Essential Issue to Contemplate within the Antibody Therapeutics in Clinic

The fragment crystallizable (Fc) area of antibodies is answerable for their protecting perform and long-lasting serum half-life by way of Fc-mediated effector perform, transcytosis, and recycling by its interplay with Fc receptors (FcRs) expressed on varied immune leukocytes, epithelial, and endothelial cells. Due to this fact, the Fc-FcRs interplay is a management level of each endogenous and therapeutic antibody perform.
There are a variety of reported genetic variants of FcRs, which embrace polymorphisms in (i) extracellular area of FcRs, which change their affinities to Fc area of antibodies; (ii) each cytoplasmic and intracellular area, which alters the extent of sign transduction; and (iii) the promoter area of the FcRs gene, which impacts the expression degree of FcRs, thus being related to the pathogenesis of illness indications.
On this assessment, we firstly describe the correlation between the genetic variants of FcRs and immunological problems by particular person variations within the extent of FcRs-mediated laws. Secondly, we focus on the affect of the genetic variants of FcRs on the susceptibility to infectious ailments or most cancers within the perspective of FcRs-induced effector capabilities. General, we concluded that the genetic variants of FcRs are one of many key components within the design of antibody therapeutics as a consequence of their number of medical outcomes amongst people.
 Potential Protection of Pre-Existent Antibodies to Human Coronavirus 229E on COVID-19 Severity

SARS-CoV-2 Spike Protein-Directed Monoclonal Antibodies Could Ameliorate COVID-19 Issues in APECED Sufferers

Sufferers with the monogenic immune dysregulatory syndrome autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), which is brought on by loss-of-function mutations within the autoimmune regulator (AIRE) gene, uniformly carry neutralizing autoantibodies directed in opposition to type-I interferons (IFNs) and lots of develop autoimmune pneumonitis, each of which place them at excessive threat for life-threatening COVID-19 pneumonia.
Bamlanivimab and etesevimab are monoclonal antibodies (mAbs) that focus on the SARS-CoV-2 spike protein and block entry of SARS-CoV-2 in host cells. Using bamlanivimab and etesevimab early throughout an infection was related to lowered COVID-19-associated hospitalization and dying in sufferers at excessive threat for progressing to extreme illness, which led the US Meals and Drug Administration to subject an emergency use authorization for his or her administration in non-hypoxemic, non-hospitalized high-risk sufferers.
Nevertheless, the protection and efficacy of those mAbs has not been evaluated in APECED sufferers. We enrolled two siblings with APECED on an IRB-approved protocol  and admitted them prophylactically on the NIH Medical Heart for analysis of mild-to-moderate COVID-19. We assessed the protection and medical results of early therapy with bamlanivimab and etesevimab.
The administration of bamlanivimab and etesevimab was effectively tolerated and was related to amelioration of COVID-19 signs and prevention of invasive ventilatory help, admission to the intensive care, and dying in each sufferers with out affecting the manufacturing of antibodies to the nucleocapsid protein of SARS-CoV-2.
If given early in the midst of COVID-19 an infection, bamlanivimab and etesevimab could also be useful in APECED and different high-risk sufferers with neutralizing autoantibodies directed in opposition to type-I IFNs.
 Potential Protection of Pre-Existent Antibodies to Human Coronavirus 229E on COVID-19 Severity

Case Report: Full Response of Main Large Hepatocellular Carcinoma to Anti-Programmed Demise Ligand-1 Antibody Following Development on Anti-Programmed Demise-1 Antibody

Hepatocellular carcinoma (HCC) is an aggressive liver tumor that happens as a consequence of persistent liver illness, and it has a excessive mortality charge and restricted therapy choices. Immune checkpoint inhibitors have been efficiently launched and utilized in most cancers remedy, amongst which inhibitors of programmed dying ligand-1 (PD-L1) and its receptor programmed death-1 (PD-1) are generally administered for HCC as mixture remedy, together with mixed anti-angiogenic and immunotherapy mixture remedy.
 Potential Protection of Pre-Existent Antibodies to Human Coronavirus 229E on COVID-19 Severity
We report a case of a main large HCC affected person with portal hepatic vein tumor thrombus who had a great response to atezolizumab together with bevacizumab, following development of illness on mixed immunotherapy with pembrolizumab and lenvatinib.

CD54 antibody

70R-13774 100 ug
EUR 322
Description: Affinity purified Rabbit polyclonal CD54 antibody

CD54 Antibody (Biotin)

abx139537-01mg 0.1 mg
EUR 425
  • Shipped within 5-12 working days.

CD54 Antibody (FITC)

abx139538-100tests 100 tests
EUR 425
  • Shipped within 5-12 working days.

CD54 Blocking Peptide

20-abx062764
  • EUR 272.00
  • EUR 411.00
  • 1 mg
  • 5 mg
  • Shipped within 5-10 working days.

CD54 (pT512) Antibody

20-abx009840
  • EUR 314.00
  • EUR 467.00
  • EUR 203.00
  • 100 ul
  • 200 ul
  • 30 ul
  • Shipped within 5-10 working days.

ICAM1/CD54 Antibody

35344-100ul 100ul
EUR 390

CD54 antibody (biotin)

61R-1516 100 ug
EUR 316
Description: Mouse monoclonal CD54 antibody (biotin)

ICAM-1/CD54

PR27037 2 ug
EUR 191

Anti-CD54 antibody

STJ16100956 100 tests
EUR 615

Anti-CD54 antibody

STJ16101113 100 µg
EUR 354

Anti-CD54 antibody

STJ190018 200 µl
EUR 197
Description: Unconjugated Mouse monoclonal to CD54 (AS1A33)

Recombinant Human α-1-Acid Glycoprotein 2/AGP2/ORM2 (C-6His)

CD54-10ug 10ug
EUR 146
Description: Lyophilized from a 0.2 μm filtered solution of 20mM Tris, 150mM NaCl, pH 8.0.

Recombinant Human α-1-Acid Glycoprotein 2/AGP2/ORM2 (C-6His)

CD54-1mg 1mg
EUR 2283
Description: Lyophilized from a 0.2 μm filtered solution of 20mM Tris, 150mM NaCl, pH 8.0.

Recombinant Human α-1-Acid Glycoprotein 2/AGP2/ORM2 (C-6His)

CD54-500ug 500ug
EUR 1613
Description: Lyophilized from a 0.2 μm filtered solution of 20mM Tris, 150mM NaCl, pH 8.0.

Recombinant Human α-1-Acid Glycoprotein 2/AGP2/ORM2 (C-6His)

CD54-50ug 50ug
EUR 303
Description: Lyophilized from a 0.2 μm filtered solution of 20mM Tris, 150mM NaCl, pH 8.0.

sICAM-1/CD54 ELISA Kit| Rat CD54 ELISA Kit

EF018233 96 Tests
EUR 689

CD54 (pY512) Blocking Peptide

20-abx062763
  • EUR 314.00
  • EUR 509.00
  • 1 mg
  • 5 mg
  • Shipped within 5-10 working days.

Anti-Ms CD54 Purified

11-625-C025 0.025 mg
EUR 76

Anti-Ms CD54 Purified

11-625-C100 0.1 mg
EUR 113

Anti-Hu CD54 APC

1A-429-T025 25 tests
EUR 140

Anti-Hu CD54 APC

1A-429-T100 100 tests
EUR 240

Anti-Hu CD54 Biotin

1B-429-C025 0.025 mg
EUR 122

Anti-Hu CD54 Biotin

1B-429-C100 0.1 mg
EUR 204

Anti-Hu CD54 FITC

1F-429-T025 25 tests
EUR 122

Anti-Hu CD54 FITC

1F-429-T100 100 tests
EUR 204

Anti-Ms CD54 FITC

1F-625-C100 0.1 mg
EUR 177

Anti-Hu CD54 Purified

11-228-C025 0.025 mg
EUR 99

Anti-Hu CD54 Purified

11-228-C100 0.1 mg
EUR 158

Anti-Hu CD54 Purified

11-229-C025 0.025 mg
EUR 99

Anti-Hu CD54 Purified

11-229-C100 0.1 mg
EUR 158

Anti-Hu CD54 PE

1P-228-T025 25 tests
EUR 140

Anti-Hu CD54 PE

1P-228-T100 100 tests
EUR 240

Anti-Hu CD54 PE

1P-429-T025 25 tests
EUR 140

Anti-Hu CD54 PE

1P-429-T100 100 tests
EUR 240

Anti-Hu CD54 PerCP

PC-429-T025 25 tests
EUR 140

Anti-Hu CD54 PerCP

PC-429-T100 100 tests
EUR 240

Monoclonal ICAM-1 / CD54 Antibody

AMM01772G 0.05mg
EUR 484
Description: A Monoclonal antibody against Human ICAM-1 / CD54. The antibodies are raised in Mouse. This antibody is applicable in IHC-P, IP, IHC-Fr, Flo

Monoclonal CD54(ICAM-1) Antibody

AMM03141G 0.1ml
EUR 484
Description: A Monoclonal antibody against Human CD54(ICAM-1). The antibodies are raised in Mouse. This antibody is applicable in WB

Monoclonal CD54(ICAM-1) Antibody

AMM03142G 0.1ml
EUR 484
Description: A Monoclonal antibody against Human CD54(ICAM-1). The antibodies are raised in Mouse. This antibody is applicable in WB, ICC

CD54 (ICAM-1) Antibody (Biotin)

abx021458-02mg 0.2 mg
EUR 739
  • Shipped within 5-10 working days.

CD54 (ICAM-1) Antibody (PE)

abx022366-100ug 100 ug
EUR 537
  • Shipped within 5-10 working days.

CD54 (ICAM-1) Antibody (Biotin)

abx022368-05mg 0.5 mg
EUR 718
  • Shipped within 5-10 working days.

Anti-Hu CD54 Alexa Fluor700

A7-429-T025 25 tests
EUR 154

Anti-Hu CD54 Alexa Fluor700

A7-429-T100 100 tests
EUR 269

CD54(ICAM-1) Monoclonal Antibody

27176-100ul 100ul
EUR 252

CD54(ICAM-1) Monoclonal Antibody

27176-50ul 50ul
EUR 187

Anti-CD54 (ICAM-1) antibody

STJ99079 200 µl
EUR 197
Description: Mouse monoclonal to CD54 (ICAM-1).

Anti-CD54 (ICAM-1) antibody

STJ99080 200 µl
EUR 197
Description: Mouse monoclonal to CD54 (ICAM-1).

Anti-CD54/ICAM-1 antibody

STJ16100016 100 µg
EUR 604

Anti-CD54/ICAM-1 antibody

STJ16100017 50 µg
EUR 519

Anti-CD54/ICAM-1 antibody

STJ16100067 100 µg
EUR 406

Anti-CD54/ICAM-1 antibody

STJ16100068 100 µg
EUR 406

Mouse Anti Human Cd54 Monoclonal Antibody

CABT-49499MH 0.2 mg
EUR 819

Mouse Anti Human Cd54 Monoclonal Antibody

CABT-46474MH 0.2 mg
EUR 741

CD54 / ICAM-1 (F4-31C2) Antibody

BNC551249-100 100uL
EUR 199
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), CF555 conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNC551249-500 500uL
EUR 544
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), CF555 conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNC611249-100 100uL
EUR 199
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), CF660R conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNC611249-500 500uL
EUR 544
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), CF660R conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNC401249-100 100uL
EUR 199
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), CF640R conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNC401249-500 500uL
EUR 544
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), CF640R conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNC431249-100 100uL
EUR 199
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), CF543 conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNC431249-500 500uL
EUR 544
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), CF543 conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNC471249-100 100uL
EUR 199
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), CF647 conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNC471249-500 500uL
EUR 544
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), CF647 conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNC051249-100 100uL
EUR 199
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), CF405M conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNC051249-500 500uL
EUR 544
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), CF405M conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNC041249-100 100uL
EUR 199
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), CF405S conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNC041249-500 500uL
EUR 544
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), CF405S conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNUB1249-100 100uL
EUR 209
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), Concentration: 0.2mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNUB1249-500 500uL
EUR 458
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), Concentration: 0.2mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNUM1249-50 50uL
EUR 395
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), 1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNC681249-100 100uL
EUR 199
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), CF568 conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNC681249-500 500uL
EUR 544
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), CF568 conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNC701249-100 100uL
EUR 199
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), CF770 conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNC701249-500 500uL
EUR 544
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), CF770 conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNC881249-100 100uL
EUR 199
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), CF488A conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNC881249-500 500uL
EUR 544
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), CF488A conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNC941249-100 100uL
EUR 199
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), CF594 conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNC941249-500 500uL
EUR 544
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), CF594 conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNCB1249-100 100uL
EUR 199
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), Biotin conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNCB1249-500 500uL
EUR 544
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), Biotin conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNCH1249-100 100uL
EUR 199
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNCH1249-500 500uL
EUR 544
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNC801249-100 100uL
EUR 199
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), CF680 conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNC801249-500 500uL
EUR 544
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), CF680 conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNCP1249-250 250uL
EUR 383
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), PerCP conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNCR1249-250 250uL
EUR 383
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), RPE conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNCA1249-250 250uL
EUR 383
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), APC conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNCAP1249-100 100uL
EUR 199
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNCAP1249-500 500uL
EUR 544
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNC811249-100 100uL
EUR 199
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), CF680R conjugate, Concentration: 0.1mg/mL

CD54 / ICAM-1 (F4-31C2) Antibody

BNC811249-500 500uL
EUR 544
Description: Primary antibody against CD54 / ICAM-1 ( F4-31C2), CF680R conjugate, Concentration: 0.1mg/mL

Human ICAM-1/CD54 ELISA Kit

EHI0332 96Tests
EUR 521

Goat ICAM-1/CD54 ELISA Kit

EGTI0332 96Tests
EUR 521

Bovine ICAM-1/CD54 ELISA Kit

EBI0332 96Tests
EUR 521

Canine ICAM-1/CD54 ELISA Kit

ECI0332 96Tests
EUR 521

Anserini ICAM-1/CD54 ELISA Kit

EAI0332 96Tests
EUR 521

sICAM-1/CD54 ELISA KIT|Human

EF002065 96 Tests
EUR 689

Porcine ICAM-1/CD54 ELISA Kit

EPI0332 96Tests
EUR 521

Rat ICAM-1/CD54 ELISA Kit

ERI0332 96Tests
EUR 521

Rabbit ICAM-1/CD54 ELISA Kit

ERTI0332 96Tests
EUR 521

Mouse ICAM-1/CD54 ELISA Kit

EMI0332 96Tests
EUR 521

Intercellular Adhesion Molecule 1 (CD54) Antibody

abx139530-01mg 0.1 mg
EUR 356
  • Shipped within 5-12 working days.

Intercellular Adhesion Molecule 1 (CD54) Antibody

abx139531-01mg 0.1 mg
EUR 356
  • Shipped within 5-12 working days.

Intercellular Adhesion Molecule 1 (CD54) Antibody

abx139532-01mg 0.1 mg
EUR 356
  • Shipped within 5-12 working days.

Intercellular Adhesion Molecule 1 (CD54) Antibody

20-abx134369
  • EUR 356.00
  • EUR 565.00
  • EUR 300.00
  • 100 ul
  • 200 ul
  • 50 ul
  • Shipped within 5-10 working days.

Intercellular Adhesion Molecule 1 (CD54) Antibody

20-abx009132
  • EUR 300.00
  • EUR 439.00
  • EUR 189.00
  • 100 ul
  • 200 ul
  • 30 ul
  • Shipped within 5-10 working days.

Intercellular Adhesion Molecule 1 (CD54) Antibody

abx021457-02mg 0.2 mg
EUR 467
  • Shipped within 5-10 working days.

Intercellular Adhesion Molecule 1 (CD54) Antibody

abx412166-01mg 0.1 mg
EUR 704
  • Shipped within 1 week.

Intercellular Adhesion Molecule 1 (CD54) Antibody

abx413013-05mg 0.5 mg
EUR 718
  • Shipped within 1 week.

Intercellular Adhesion Molecule 1 (CD54) Antibody

abx413228-02mg 0.2 mg
EUR 565
  • Shipped within 1 week.

Intercellular Adhesion Molecule 1 (CD54) Antibody

abx413229-05mg 0.5 mg
EUR 829
  • Shipped within 1 week.

Intercellular Adhesion Molecule 1 (CD54) Antibody

abx413232-01mg 0.1 mg
EUR 439
  • Shipped within 1 week.

Intercellular Adhesion Molecule 1 (CD54) Antibody

abx413235-20ug 20 ug
EUR 272
  • Shipped within 1 week.

Intercellular Adhesion Molecule 1 (CD54) Antibody

abx415026-02mg 0.2 mg
EUR 565
  • Shipped within 1 week.

Intercellular Adhesion Molecule 1 (CD54) Antibody

abx415028-25ug 25 ug
EUR 272
  • Shipped within 1 week.

Intercellular Adhesion Molecule 1 (CD54) Antibody

abx415520-02mg 0.2 mg
EUR 565
  • Shipped within 1 week.

Intercellular Adhesion Molecule 1 (CD54) Antibody

abx415521-05mg 0.5 mg
EUR 829
  • Shipped within 1 week.

Intercellular Adhesion Molecule 1 (CD54) Antibody

abx415524-01mg 0.1 mg
EUR 439
  • Shipped within 1 week.

Human CellExp? ICAM1 /CD54, human recombinant

7486-100
EUR 718

Human CellExp? ICAM1 /CD54, human recombinant

7486-20
EUR 267

ICAM-1(CD54) Mouse Monoclonal Antibody

Ab12144-100 100ul
EUR 482

VCAM-1(CD54) Mouse Monoclonal Antibody

Ab73313-050 50ul
EUR 469

VCAM-1(CD54) Mouse Monoclonal Antibody

Ab73313-100 100ul
EUR 604

Anti-Hu CD54 Purified Azide Free

10-429-C025 0.025 mg
EUR 99

Anti-Hu CD54 Purified Azide Free

10-429-C100 0.1 mg
EUR 158

Anti-Ms CD54 Purified Low Endotoxin

12-625-C100 0.1 mg
EUR 149

anti-CD54 IgG2b-k monoclonal antibody

068-A-01mg 0,1 mg
EUR 267.5
  • Category: Antibody, Signal Transduction Antibodies, mAb
Description: anti-CD54 IgG2b-k monoclonal antibody

anti-CD54 IgG2b-k monoclonal antibody

068-A-1000ug 1000 ug
EUR 1282.5
  • Category: Antibody, Signal Transduction Antibodies, mAb
Description: anti-CD54 IgG2b-k monoclonal antibody

Rabbit Anti Human Cd54 Polyclonal Antibody

CPBT-65044RH 0.1 mg
EUR 881

Anti-CD54 / ICAM-1 Monoclonal Antibody

M00171 100ug/vial
EUR 397
Description: Mouse Monoclonal CD54 / ICAM-1 Antibody. Validated in IHC and tested in Human.

Anti-ICAM1/Cd54 Rabbit Monoclonal Antibody

M00171-1 100ug/vial
EUR 397
Description: Rabbit Monoclonal ICAM1/Cd54 Antibody. Validated in IF, WB and tested in Human.

Recombinant Human ICAM-1/CD54 Protein

RP00272 5 μg
EUR 136

Recombinant Mouse ICAM-1/CD54 Protein

RP01056 5 μg
EUR 136

Recombinant Mouse ICAM-1/CD54 Protein

RP01065 10 μg
EUR 193

Mouse Anti Human Cd54 Monoclonal Antibody,FITC

CABT-46466MH 0.1 mg
EUR 663

Mouse Anti Human Cd54 Monoclonal Antibody,RPE

CABT-46472MH 100 TEST
EUR 710

Mouse Anti Rat Cd54 Monoclonal Antibody,RPE

CABT-46486MR 100 TEST
EUR 767

Human Intercellular Adhesion Molecule 1 (CD54) Protein

abx670234-50ug 50 ug
EUR 565
  • Shipped within 1 week.

Guinea Pig ICAM-1/CD54 ELISA Kit

EGI0332 96Tests
EUR 521

Intercellular Adhesion Molecule 1 (CD54) Antibody (PE)

abx139533-100tests 100 tests
EUR 481
  • Shipped within 5-12 working days.

Intercellular Adhesion Molecule 1 (CD54) Antibody (PerCP)

abx139534-100tests 100 tests
EUR 481
  • Shipped within 5-12 working days.

Intercellular Adhesion Molecule 1 (CD54) Antibody (PE)

abx139535-100tests 100 tests
EUR 481
  • Shipped within 5-12 working days.

Intercellular Adhesion Molecule 1 (CD54) Antibody (APC)

abx139536-100tests 100 tests
EUR 481
  • Shipped within 5-12 working days.

Intercellular Adhesion Molecule 1 (CD54) Antibody (PE)

abx134368-100Assays 100 Assays
EUR 495
  • Shipped within 5-10 working days.

Intercellular Adhesion Molecule 1 (CD54) Antibody (PE)

abx134368-50Assays 50 Assays
EUR 398
  • Shipped within 5-10 working days.

Intercellular Adhesion Molecule 1 (CD54) Antibody (Biotin)

abx412167-50ug 50 ug
EUR 718
  • Shipped within 1 week.

Intercellular Adhesion Molecule 1 (CD54) Antibody (FITC)

abx413230-01mg 0.1 mg
EUR 509
  • Shipped within 1 week.

Intercellular Adhesion Molecule 1 (CD54) Antibody (FITC)

abx413231-25ug 25 ug
EUR 272
  • Shipped within 1 week.

Intercellular Adhesion Molecule 1 (CD54) Antibody (RPE)

abx413233-100tests 100 tests
EUR 592
  • Shipped within 1 week.

Intercellular Adhesion Molecule 1 (CD54) Antibody (RPE)

abx413234-25tests 25 tests
EUR 314
  • Shipped within 1 week.

Intercellular Adhesion Molecule 1 (CD54) Antibody (FITC)

abx415027-100tests 100 tests
EUR 509
  • Shipped within 1 week.

Intercellular Adhesion Molecule 1 (CD54) Antibody (FITC)

abx415522-01mg 0.1 mg
EUR 509
  • Shipped within 1 week.

Intercellular Adhesion Molecule 1 (CD54) Antibody (FITC)

abx415523-05mg 0.5 mg
EUR 718
  • Shipped within 1 week.

CD54 (ICAM1) FITC Monoclonal Antibody (Clone 15.2)

6961-100
EUR 370

CD54 (ICAM1) FITC Monoclonal Antibody (Clone 15.2)

6961-25
EUR 196

Rabbit Anti Human Cd54 Polyclonal Antibody,Biotin

CPBT-65043RH 50 µg
EUR 881

ELISA kit for Human sICAM-1 (CD54)

KET6003-48T 48T
EUR 202
  • ICAM-1 (Intercellular Adhesion Molecule 1) also known as CD54 (Cluster of Differentiation 54) is a protein that in humans is encoded by the ICAM1 gene. ICAM-1 is a member of the immunoglobulin superfamily, the superfamily of proteins including antibo
  • Show more
Description: Quantitative sandwich ELISA for measuring Human sICAM-1 (CD54) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Human sICAM-1 (CD54)

KET6003-5platesof96wells 5 plates of 96 wells
EUR 1077
  • ICAM-1 (Intercellular Adhesion Molecule 1) also known as CD54 (Cluster of Differentiation 54) is a protein that in humans is encoded by the ICAM1 gene. ICAM-1 is a member of the immunoglobulin superfamily, the superfamily of proteins including antibo
  • Show more
Description: Quantitative sandwich ELISA for measuring Human sICAM-1 (CD54) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Human sICAM-1 (CD54)

KET6003-96T 96T
EUR 289
  • ICAM-1 (Intercellular Adhesion Molecule 1) also known as CD54 (Cluster of Differentiation 54) is a protein that in humans is encoded by the ICAM1 gene. ICAM-1 is a member of the immunoglobulin superfamily, the superfamily of proteins including antibo
  • Show more
Description: Quantitative sandwich ELISA for measuring Human sICAM-1 (CD54) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

Hamster Anti Mouse Cd54 Monoclonal Antibody,Azide Free

CABT-46477HM 0.5 mg
EUR 965

Anti-CD54/ ICAM-1 Antibody [15.2], Unconjugated-100ug

QAB47-100ug 100ug
EUR 157

Anti-CD54/ ICAM-1 Antibody [15.2], APC-100Tests

QAB47-APC-100Tests 100Tests
EUR 335

Anti-CD54/ ICAM-1 Antibody [15.2], APC-25Tests

QAB47-APC-25Tests 25Tests
EUR 166

Anti-CD54/ ICAM-1 Antibody [15.2], FITC-100Tests

QAB47-F-100Tests 100Tests
EUR 251

Anti-CD54/ ICAM-1 Antibody [15.2], FITC-25Tests

QAB47-F-25Tests 25Tests
EUR 141
This case demonstrates for the primary time that an HCC affected person who’s proof against anti-PD-1 antibody immunotherapy can profit from anti-PD-L1 antibody immunotherapy, offering a probably promising technique for the therapy of HCC.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Post